Craft
  • Home
  •  / JCR Pharmaceuticals
JCR Pharmaceuticals

JCR Pharmaceuticals

Revenue

¥51.1 B

FY, 2022

Market Capitalization

¥259.5 B

2022-09-20

JCR Pharmaceuticals Summary

Company summary

Overview
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products. It is engaged in the research and discovery of therapeutic drugs for lysosomal storage diseases. The company focuses on blood-brain barrier penetration technology, tissue-targeting technology, as well as cell therapy and regenerative medicine.
Type
Public
Founded
1975
HQ
Ashiya, JP | view all locations
Website
https://www.jcrpharm.co.jp/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Shin Ashida, Chairman, President and CEO

    • Toru Ashida, Vice President

      • Hiroyuki Sonoda, Senior Executive Director

        • Mathias Schmidt, Senior Executive Director

          LocationsView all

          1 location detected

          • Ashiya, Hyogo HQ

            Japan

            3-19 Kasugachō

          JCR Pharmaceuticals Financials

          Summary financials

          Revenue (FY, 2022)
          ¥51.1B
          Gross profit (FY, 2022)
          ¥42.6B
          Net income (FY, 2022)
          ¥14.5B
          Cash (FY, 2022)
          ¥30.7B
          EBIT (FY, 2022)
          ¥18.8B
          Enterprise value
          $246.8B

          Footer menu